Estadístiques de Atezolizumab monotherapy for metastatic urothelial carcinoma: final analysis from the phase II IMvigor210 trial
Visites totals
| views | |
|---|---|
| Atezolizumab monotherapy for metastatic urothelial carcinoma: final analysis from the phase II IMvigor210 trial | 10 |
Visites totals per mes
| views | |
|---|---|
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 10 |
| December 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| Rosenberg_eo_atez.pdf | 27 |
| Rosenberg_eo_atez.pdf | 3 |